What is Wavely Diagnostics?
Wavely Diagnostics is pioneering the future of remote digital diagnostics, enabling telehealth growth by leveraging smartphone technology to address pediatric care. The company's innovative approach allows for accessible and efficient healthcare solutions, positioning it as a key player in the rapidly expanding digital health and telehealth market. By integrating advanced diagnostic tools with ubiquitous mobile devices, Wavely Diagnostics aims to improve patient outcomes and streamline healthcare delivery for children.
How much funding has Wavely Diagnostics raised?
Wavely Diagnostics has raised a total of $3.5M across 2 funding rounds:
Angel/Seed
$2.2M
Other Financing Round
$1.4M
Angel/Seed (2022): $2.2M with participation from WXR Fund, WRF Capital, Gaingels Spark Fund, Ambit Health Ventures, HealthTech Capital, and Cascade Seed Fund
Other Financing Round (2023): $1.4M led by Robin Hood Ventures, HealthTech Capital, and WRF Capital
Key Investors in Wavely Diagnostics
Robin Hood Ventures
Robin Hood Ventures is a leading angel investment group based in Philadelphia, specializing in early-stage, high-growth startups. They provide investments ranging from $250,000 to $1 million and collaborate with venture capitalists and other angel investors, offering capital and guidance to entrepreneurs across various industries including Software/Healthcare IT, Hardtech, Life Sciences, and Consumer.
HealthTech Capital
HealthTech Capital is a private investment organization focused on healthtech and digital health startups, providing funding and mentoring since 2010. The company connects accredited angel investors, healthcare systems, and corporate investors to support early-stage healthtech ventures, aiming to foster innovation in healthcare delivery.
WRF Capital
Washington Research Foundation (WRF) is a leading early-stage investor focused on transforming innovative ideas into successful businesses in Washington. Since 1996, WRF has invested approximately $5 million annually in local startups, particularly those emerging from nonprofit research institutions, specializing in life sciences, information technology, and physical sciences.
What's next for Wavely Diagnostics?
The recent major strategic investment signals a new phase of expansion for Wavely Diagnostics, likely focusing on scaling its operations, enhancing its technological infrastructure, and broadening its market reach. This capital will empower the company to further develop its remote diagnostic platform, potentially exploring new pediatric specialties and geographical markets. The strategic backing suggests a strong confidence in Wavely Diagnostics' business model and its potential to disrupt traditional pediatric healthcare delivery, paving the way for sustained growth and innovation in the telehealth sector.
See full Wavely Diagnostics company page
